Drug Safety Alerts

Telmisartan 20 mg tablets manufactured by Alembic Pharmaceuticals Limited Consumer-Level Recall

3/24/2021

On March 24, 2021, the United States Food and Drug Administration (FDA) published a consumer-level recall of Telmisartan 20 mg tablets NDC #62332-0087-30 manufactured by Alembic Pharmaceuticals Limited. This recall is being issued due to a market complaint received which stated that one bottle labelled as 30-count Telmisartan 20 mg tablets incorrectly contained 30 tablets of Telmisartan 40 mg tablets.

This may represent a potential health hazard or safety risk to patients using product affected by this recall.

This recall affects lot 1905005661 exp. 03/2022.

Alembic Pharmaceuticals Limited recommends that consumers should continue taking Telmisartan 20 mg tablets until they consult with their doctor who can prescribe a replacement. Patients should contact their health care professional right away for advice if they may be using affected product or if they do not know if you used affected drug.

CVS Caremark Response: Because of this action, CVS Caremark® is sending letters to members who received this product through CVS Caremark® Mail Service Pharmacy and their physicians.

For more information, call the United States Food and Drug Administration (FDA) toll-free at 1 888 INFO-FDA (1 888-463-6332) or visit https://www.fda.gov.